Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Shinkin Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 49
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 44
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.10
Exits 4
Key employees Soon

Areas of investment

  • Manufacturing
  • Food and Beverage
  • Biotechnology
  • Construction
  • Medical Device
Summary

The fund was located in Asia if to be more exact in Japan. The main office of represented VC is situated in the Tokyo.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Linkwiz, REGiMMUNE Corporation. Among the most popular fund investment industries, there are Biopharma, Robotics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Shinkin Capital, startups are often financed by Japan Asia Investment, Yasuda Enterprise Development, SMBC Venture Capital. The meaningful sponsors for the fund in investment in the same round are SMBC Venture Capital, Hamashin Lease, Shizuoka Capital Wealth Management. In the next rounds fund is usually obtained by Venture Labo Investment Co.,Ltd, SMBC Venture Capital, Toppan Forms.

The top activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 1 - 5 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Shinkin Capital:
Typical Co-investors
Shinkin Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Shinkin Capital:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
70Ventures Lithuania, Vilniaus Apskritis, Vilnius
AshHill Biomedical Cincinnati, Ohio, United States
Black Capital -
Caitong Capital China, Hangzhou, Zhejiang
Careismatic Brands California, Chatsworth, United States
Cherry Tree Investments California, Los Angeles, United States
Draper Cambridge, Massachusetts, United States
EXPERT DOJO California, Santa Monica, United States
Garnett & Helfrich Capital California, San Mateo, United States
IntelleGrow India, Maharashtra, Mumbai
MAR ventures Brazil, São Paulo, Sao Paulo
MB Venture Partners Memphis, Tennessee, United States
Merieux Developpement France, Lyon, Rhone-Alpes
Netmarble Seoul, Seoul-t'ukpyolsi, South Korea
Next News Ventures New York, New York, United States
NREP -
Oxford University Innovation Oxford, Oxfordshire, United Kingdom
Shanghai Bingye Qiye Guanlizhongxin China, Shanghai
University Medical Center Groningen Groningen, Groningen, The Netherlands
Xiamen Torch Group Co China, Fujian, Xiamen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

KOTOBUKI Medical

Health Care
Manufacturing
Medical
Medical Device
$728K28 May 2021 Soka, Saitama Prefecture, Japan

NOKIOO

Marketing
Marketing Automation
Multi-level Marketing
13 Apr 2021 Hamamatsu, Shizuoka Prefecture, Japan

DAIZ

Food and Beverage
Food Processing
$17M31 Mar 2021 Kumamoto, Kumamoto Prefecture, Japan

Fairy Devices

Android
Internet
Web Development
24 Feb 2021 Chiyoda, Japan

ANSeen

Real Estate
$8M07 Sep 2020 Japan, Shizuoka Prefecture

Linkwiz

Artificial Intelligence
Robotics
Software
$8M18 Jun 2019 Japan, Shizuoka Prefecture

ANSeen

Real Estate
$2M21 Nov 2018 Shizuoka, Shizuoka Prefecture, Japan

AI Samurai

Artificial Intelligence
Information Technology
Product Research
$1M30 Oct 2018 Japan, Chiyoda

REGiMMUNE Corporation

Biopharma
Biotechnology
Health Diagnostics
$5M01 Feb 2012 Chiyoda

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Shinkin Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 49
Average round size 1M
Peak activity year 2015
Lead investments 0
Follow on index 0.10
Exits 4
Group Appearance index 0.41

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

KOTOBUKI Medical

Health Care
Manufacturing
Medical
Medical Device
$728K28 May 2021 Soka, Saitama Prefecture, Japan

NOKIOO

Marketing
Marketing Automation
Multi-level Marketing
13 Apr 2021 Hamamatsu, Shizuoka Prefecture, Japan

DAIZ

Food and Beverage
Food Processing
$17M31 Mar 2021 Kumamoto, Kumamoto Prefecture, Japan

Fairy Devices

Android
Internet
Web Development
24 Feb 2021 Chiyoda, Japan

ANSeen

Real Estate
$8M07 Sep 2020 Japan, Shizuoka Prefecture

Linkwiz

Artificial Intelligence
Robotics
Software
$8M18 Jun 2019 Japan, Shizuoka Prefecture

ANSeen

Real Estate
$2M21 Nov 2018 Shizuoka, Shizuoka Prefecture, Japan

AI Samurai

Artificial Intelligence
Information Technology
Product Research
$1M30 Oct 2018 Japan, Chiyoda

REGiMMUNE Corporation

Biopharma
Biotechnology
Health Diagnostics
$5M01 Feb 2012 Chiyoda
Crunchbase icon

Content report

The following text will be sent to our editors: